Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010259 |
---|---|
Receipt number | R000012008 |
Scientific Title | A Phase II Study of Bi-weekly XELOX with Bevacizumab for patient with Metastatic Colorectal Cancer as first-line chemotherapy |
Date of disclosure of the study information | 2013/03/17 |
Last modified on | 2022/03/28 08:22:30 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/03/17 10:12:07 | ||
2 | Update | 2014/03/17 09:05:46 | Last name of lead principal investigator Last name of lead principal investigator |
|
3 | Update | 2016/09/18 11:15:54 | Name of primary person or sponsor Organization |
|
4 | Update | 2020/03/23 08:26:11 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
5 | Update | 2020/03/23 08:31:59 | Date of IRB Last follow-up date |
|
6 | Update | 2022/03/28 08:22:30 | Recruitment status Last follow-up date |